Close X
Attorney Spotlight

Find out which two countries Cheryl Palmeri gets the most questions about related to International Trade in today's market? Find out more>


Close X


Search our Experience

Experience Spotlight

In June 2016, AmSurg Corp. and Envision Healthcare Holdings, Inc. (Envision) announced they have signed a definitive merger agreement pursuant to which the companies will combine in an all-stock transaction. Upon completion of the merger, which is expected to be tax-free to the shareholders of both organizations, the combined company will be named Envision Healthcare Corporation and co-headquartered in Nashville, Tennessee and Greenwood Village, Colorado. The company's common stock is expected to trade on the New York Stock Exchange under the ticker symbol: EVHC. Bass, Berry & Sims served as lead counsel on the transaction, led by Jim Jenkins. Read more.

AmSurg logo

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Inside the FCA blogInside the FCA blog features ongoing updates related to the False Claims Act (FCA), including insight on the latest legal decisions, regulatory developments and FCA settlements. The blog provides timely updates for corporate boards, directors, compliance managers, general counsel and other parties interested in the organizational impact and legal developments stemming from issues potentially giving rise to FCA liability.

Read More >

Taylor Chenery Authors Law360 Article on FCA Liability



September 23, 2016

Bass, Berry & Sims attorney Taylor Chenery authored an article for Law360 addressing how ambiguities within complex government rules and regulations can lead to multiple interpretations and potentially expose a healthcare provider or government contractor to FCA liability.  "The question necessarily arises, then, at what point a provider's or contractor's regulatory interpretation may expose it to the harsh damages and penalties accompanying FCA liability rather than some lesser sanction if that interpretation ultimately differs from the government's or a court's," said Taylor. 

In the article, Taylor cites the Eighth Circuit's opinion in U.S. ex rel. Donegan v. Anesthesia Associates of Kansas City PC as the most recent case addressing this issue, suggesting that a provider faced with a potentially ambiguous regulation or statute can protect itself from possible FCA liability by taking steps to ensure that its interpretation of the ambiguous rule is reasonable under the circumstances. In the Donegan case, the Eighth Circuit affirmed the district court's ruling that the provider strongly demonstrated that its interpretation of a billing regulation was objectively reasonable in part because an unclear term had not been clarified by the government, government contractors or professional organizations.

The full article, "When Ambiguous Regs Preclude FCA Liability," was published by Law360 on September 22, 2016, and is available online. To learn more about this issue, read Taylor's blog post on the Inside the FCA blog from August 19, 2016, "Eighth Circuit Affirms Dismissal of FCA Claims Related to Ambiguous Regulation."

In Case You Missed It:

Related Professionals

Related Services


Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.